In this rapid, cost-effective,enzyme-linked immunosorbent assay for 17a-hydroxyprogesterone(17-OHP) eluted from driedbloodspottedon filterpaper, secondantibodyis coated onto the microwell plate and horseradish peroxidase (EC 1.11.1.7) is the label enzyme. Antiserum to 17-OHP was prepared by using 4-(2-carboxyethylthio)-1 7-OHP-bovine serum albuminconjugateas immunogen.Enzymeconjugate was prepared from 4-(2-carboxymethylthio)-1 7-OHP and peroxidase.The blood spots are assayed in the microwells withoutextractionor centnfugationsteps. The detectionlimit of the assay is 1 ig/L, equivalent to 3.5 pg (10.6 fmol) per disc. Intra-and interassayCVs at two steroidconcentrations (7.38 and 22.79 g/L) ranged from 3.74 to 11.90% (n = 5), and 9.49 and 9.83% (n = 5), respectively.Resultscorrelated well (r = 0.91) with those of a fluorescenceenzyme immunoassay. The sensitivity,specificity,and precisionof this method make it potentially useful in the mass screening of neonates for congenitaladrenal hyperplasia. For the present study we have prepared a specific anti-17-01W antiserum by using as immunogen 4-(2-carboxyethylthio)-17a-hydroxyprogesterone (4-CET-17-OHP) conjugated with bovine serum albumin.
01W in blood spots, with a radioactive iodinated 17-01W tracer. Huble et al. (8) reported an enzyme immunoassay of 17-01W in plasma or dried blood on a paper disc and in saliva of newborns, children, and patients with CAN. However, their method was insufficiently sensitive to detect the 17-01W in a 3-mm (diameter) dried blood disc. Moreover, extraction with methylene chloride and centrifugation were needed, to precipitate the bound fraction. Klingler et al. (9) developed a chemiluminescent imrnunoassay of 17-01W with isoluminol derivative as a label and applied this to School of Pharmaceutical Sciences, Showa University, Hatanodai, Shinagawa-ku, Tokyo 142, Japan.
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Materials and Methods

Apparatus
ELISA plates ("Microwell plate 96F without LID-PS-SH") were obtained from Nunc Co., DK 4000 Roskilde, Denmark. Plastic film "MS-300," used to cover the plates, was from Sumitomo Bakelite Co., Tokyo. Samples 17-01W-free serum was prepared by treating pooled human serum with charcoal (13). Erythrocytes in heparinized blood from apparently normal subjects were washed twice with isotonic saline, once with 17-01W-free serum, and then recombined with 17-01W-free serum to adjust the hematocrit to 55%, to mimic the higher hematocrit in newborns. To this material we added known amounts of 17-01W to give final concentrations of 0, 1.25, 2.50, 6.25, 12.5, 25.0, 62.5, 125, and 250 jzg/L in whole blood. These 17-01W blood standards were then spotted on filter-paper cards used in infant screening (Toyo Filter Paper Co., Tokyo, Japan), to serve as standards for the dried-blood discs.
Procedure
Antiserum preparation. Antiserum to 17-01W was raised in rabbits by using 4-CET-17-OHP-albumin conjugate as imniunogen, prepared as described previously (10). This antiserum is highly specific, as characterized by RIA (14). Before use, we diluted the anti-17-O1W serum 80 000-fold with the assay buffer. The second antibody was goat antirabbit IgG (affinity-purified IgG fraction, 4.1 g/L) from Miles-Yeada Co., Israel. Enzyme conjugate. We prepared 17-O1W-HRP conjugate by the mixed-anhydride method as previously described (10).
Coating of second antibody to the microwell plates. Microwell plates were coated by adding 200 pL per well of 20 mg/L goat antiserum to rabbit IgG, a solution in coating buffer. The plates were left overnight at 4#{176}C. The IgG solution was removed and any remaining binding sites were blocked by adding to each well 300 L of a 10 g/L bovine serum albumin solution containing 0.5 of sodium azide per liter. The coated plates, covered with the plastic film, are stable for at least two to three months at 4#{176}C. Before use, each plate was washed with 300 pL of assay buffer per well and excess fluid removed by tapping the inverted plate on a paper towel.
Direct assay. The discs (3 mm in diameter) were punched out from spots of standard or dried-blood sample on ifiter paper cards, allowed to fall directly onto the appropriate wells of the plate, followed by 100 pL of assay buffer, 50 uL of 1:80 000 diluted anti-17-O1W antiserum, and 50 pL of 1:3000 diluted 17-O1W-HRP conjugate. The plate was covered with the plastic ifim, shaken by swirling, and left overnight at 4#{176}C. The contents of the plate were then aspirated and the wells were washed three times with assay buffer by use of the 12-channel aspirator. The plate was then inverted over a paper towel. To each well, 150 L of the ABTS-H202 substrate solution was added, and the color was allowed to develop in the dark for 2 h at room temperature.
Then 50 pL of a 1 g/L sodium azide solution was added to terminate the enzymatic reaction, and absorbances were measured at 420 nm with a semi-automatic microplate reader. All standards and samples were run in duplicate.
The computer evaluated and edited the data, plotted the standard curve, and calculated the assay statistics and the concentration of 17-01W in dried blood discs.
Extraction assay. Samples with high values for 17-01W, as detected by the direct assay, were confirmed by the extraction assay. One disc was placed in glass culture tube and eluted for 2 h at room temperature by addition of 500 iL of isotonic saline. To extract steroids we used 1 mL of diethyl ether and vigorous shaking on a vortex-mixer for 1 mm. The tube was dipped into solid C02-acetone to freeze the water layer. The ether extract was transferred to another tube, evaporated under nitrogen, and the residue was dissolved in 100 pL of assay buffer. Fifty microliters of the resulting solution was then subjected to the ELISA as outlined for the direct assay.
Fluorescence EJA of 17-OHP. The previous method (10) was used for comparison with the ELISA method.
Preliminary application to mass-screening. Duplicate dried-blood samples obtained from 5558 neonates (ages five to seven days) were assayed by the ELISA, either the direct or the extraction assay.
Results
Optimal assay conditions. As a compromise between sensitivity and precision, we used an 800 000-fold dilution of the antiserum to 17-01W in the assay. Increasing the dilution of the 17-OIW-peroxidase conjugate solution from 1500-to 5000-fold improved assay sensitivity, but the absorbance at B0 decreased, as did the precision of the assay. Therefore, we used 3000-fold-diluted 17-01W-peroxidase conjugate solution in all subsequent assays.
Standard curves. Figure 1 shows typical standard curves for 17-01W in dried blood discs, for both the direct assay and the extraction assay. The CV for each point ranged from 3.78 to 10.70% (mean 6.60%) for the direct assay, 5.40 to 11.60% (mean 6.80%) for the extraction assay. The limit of detection for 17-01W (i.e., the response distinguishable from that for zero 17-01W) was 1 g/L. Intra-and interassay CVs were evaluated by testing five replicates each of samples with low and high 17-01W concentrations in dried blood: samples A (7.38 1ig/L) and B (22.79 ig/L). Intra-assay CVs ranged from 3.80 to 11.90% (n = 5) and 3.74 to 10.45% (n = 5) for samples A and B. Interassay CVs were 9.49 and 9.83% (n = 5) for samples A and B.
Correlation with the fluorescence enzyme immunoassay for 1 7-OHP. Using the present ELISA (y) and the fluorescence enzyme immunoassay for 17-OHP (x) reported in the previous paper (10), we assayed, in duplicate, 80 samples of dried blood from neonates. The linear correlation coeffIcient between the 17-01W values as determined by those two methods was 0.910, the slope 0.780, and the y-intercept -1.940.
Antibody specificity. We evaluated the specificity of the antiserum we prepared by assaying potentially cross-reacting steroids. Table 1 we assayed samples from two CAN patients and five samples from premature infants by the direct assay and the extraction assay. As shown in Table 2 Fig. 2 . Distribution frequency of 17a-hydroxyprogesterone concentrationindried biood discs as detemiined byuse of the EUSA corresponding to 50 pg per disc. We examined these by the extraction assay. As shown in the inset to Figure 2 , the values were lower than those obtained in the direct assay, the mean 17-01W value for these samples being 2.1 pg/L.
Discussion
The specificity of an antiserum for steroids is markedly influenced by which position on the steroid molecule is used for conjugation to the carrier protein. Hosoda et al. (15) suggested that conjugation at carbon 4 is effective in preparing specific antiserum against testosterone or cortisol. Guided by this, we used a C-4 conjugate as the immunogen in this study. Cross reactiviti#{233}s to some steroids that are similar to 17-01W in structure or are present in abnormally high concentrations in the blood of neonates were measured by the fluorescence enzyme immunoassay and compared with the cross reactivity of the previous anti-17-01W antiserum, which was prepared by using 3-carboxymethyl oxime-17-01W-bovine serum albumin (10). As shown in Table 1 , the specificity of the antiserum used here was superior to that of the previous antiserum prepared by using a carbon-3 derivative.
The sensitivity of enzyme immunoassays for steroids is affected by the combination of antibody and enzyme-labeled steroid derivative, that is, whether it is a "homologous" or "heterologous" system. Van Weemen and Schuurs (16) suggested that the sensitivity of enzyme immunoassay for estrogen could be considerably improved by using heterologous systems. Hosoda et al. (17) systematically examined many steroid derivatives and antisera against them and reached the same conclusion, as did we for cortisol (18), dehydroepiandrosterone (19), and thyroxin (20). Therefore, we examined homologous and heterologous systems of 17-01W derivatives:
3-O-carboxymethyl oxime-, 4-carboxymethylthio-, 4-carboxyethylthio-, 11-hemisuccinoxy-, and the C-7 derivative (obtained from Miles Co.) (14) . Among them, the bridge heterologous combination, involving antiserum prepared by using 4-carboxyethylthio-17-OIW-bovine serum albumin and 4-carboxymethylthio-horseradish peroxidase conjugate, was the most sensitive enzyme immunoassay for 17-01W. The bridge heterologous system, in which a shorter bridge is used in enzyme labeling than that in the homologous or the longer bridge system, can increase the sensitivity because antibody and labeled enzyme lower the affinity of antibody for the antigemc determinant in the labeled antigen (17) . Guided by the previous results, we used the bridge heterologous system in this ELISA method. In general, the colorimetry is less sensitive than the fluorophotometric method, but the sensitivity of the present ELISA is almost the same as that of the previous fluorescence enzyme immunoassay in which peroxidase was used as the label (10). The detection limit of the present ELISA is 1 .tg/L, equivalent to 3.5 pg (10.6 fmol) per disc if the volume of blood in one 3-mm disc is calculated to be 3.6 j.og/L. This sensitivity suffices for use in mass screening for CAN, because the cutoff value for CAN proposed by Pang et al. pg/disc, but normal by the extraction assay. Therefore, we can detect CAN in a neonate by the combination of direct assay and extraction assay.
As shown in Figure 2 , 630 samples with high 17-01W concentrations by the direct assay showed normal values by the extraction assay. Closely related water-soluble steroids, such as 17-hydroxypregnenolone-3-sulfate, probably are responsible for this discrepancy. Although such steroids cross react with the anti-17-O1W antiserum used in this study only to a small extent, as illustrated in Table 1 , they are present in exceptionally high concentrations during the neonatal period of premature babies. Those steroids could be eliminated by extraction with ether. The cutoff value for 17-01W to be used in screening for CAN will be decided by the specificity of antiserum used in the assay. We are doing a large-scale preliminary mass-screening test to decide the cutoff value for the direct assay presented here.
